NF2-_AC-CRISPR-A17 drug treatment.xlsx

syn30384691

Created By Roberta Beauchamp Beauchamp

age:
sex:
Uuid: a90e5b90-9d9d-476b-9c0f-89d49d0d3ee2
assay: cell viability assay
organ:
tissue:
ageUnit:
species: Homo sapiens
studyId: syn27761862
cellType: arachnoid
comments: data represents dose response of cell lines to drug treatment (expressed as % viability) in drug treated cells compared to DMSO control treatment
dataType: drugScreen
entityId: syn30384691
platform: EnVision 2103 Multiplate Reader
Component: PlateBasedReporterAssayTemplate
aliquotID:
diagnosis:
studyName: Leveraging Synodos NF2 data to test novel single and combination drugs in NF2-deficient meningioma models
tumorType:
fileFormat:
initiative: Drug Discovery Initiative Registered Reports
isCellLine: Yes
specimenID:
dataSubtype: processed
nf1Genotype:
nf2Genotype: -/-
individualID:
reporterGene:
resourceType: experimentalData
fundingAgency: CTF
isPrimaryCell: No
timePointUnit: hours
platformTarget:
modelSystemName: NF2-/- AC007-hTERT
parentSpecimenID:
reporterSubstance:
progressReportNumber: 10
experimentalCondition: drug treated vs DMSO
experimentalTimepoint: 72
specimenPreparationMethod:

NF2-_AC-CRISPR-A17 drug treatment.xlsx page is loading…